Brian Conn's Location
San Diego, California, United States, United States
Brian Conn's Contact Details
Brian Conn work email
- Valid
- Valid
- Valid
- Valid
- Valid
Brian Conn personal email
n/a
Brian Conn phone numbers
About Brian Conn
A financial executive with broad experience in both financial and non-financial aspects of business including:-Raising capital for early and growth stage companies-Financial management, budgeting, forecasting and analysis.-SEC reporting and compliance, corporate governance, Sarbanes-Oxley.-Mergers and acquisitions sell and buy side.-Investor relations and corporate communication.-Project management including software development, reorganizations and other business initiatives.-General business management (domestic and international) including all aspects of business development and administration.Specialties: ERP implementationsMergers and AcquisitionsInternational
Brian Conn Work Experience Details
-
Cofounder And Chief Financial OfficerAbtherx 2023 - PresentMountain View, Ca, Us -
Cofounder And Chief Financial OfficerPyrone Systems Inc. 2021 - PresentSan Diego, Us -
Chief Financial OfficerSwitchback Systems 2021 - PresentSan Francisco Bay Area, Us -
DirectorBiosensis Pty Ltd Apr 2012 - PresentThebarton, South Australia, AuBiosensis specializes in antibodies and reagents for Neuroscience, with particular emphasis on neurotrophins and neurotrophin receptors. -
AdvisorKiverdi, Inc. Feb 2017 - PresentPleasanton, California, Us -
Interim Chief Financial OfficerRa Medical Systems 2022 - 2023Carlsbad, Ca, UsRa Med (NYSEA: RMED)has developed a minimally-invasive excimer laser and catheter system to treat vascular blockages. I joined in Q2 of 2022 to help identify and pursue strategic options. After a thorough evaluation of alternatives, the company decided to move forward on a reverse merger with Catheter Precision, a medical device company focused on the field of cardiac electrophysiology. On September 12, 2022, we announced signing a merger agreement which was closed on January 9, 2023. I am currently helping to complete the integration and ensuring that the newly-combined company stays compliant with reporting requirements during the transition. -
Chief Financial OfficerPhenovista Biosciences 2021 - 2023San Diego, California, Us -
Cfo And CofounderLevadura Biotechnology Jan 2019 - Oct 2021San Diego, Ca, Us -
Chief Financial OfficerQuantapore Inc. 2017 - 2021Quantapore Inc. is developing a novel, nanopore based nucleic acid sequencing technology. Unlike other nanopore approaches, Quantapore utilizes an optical read out which results in lower cost and higher throughput compared to electrical data acquisition.
-
Chief Financial OfficerImagion Biosystems, Inc Jul 2016 - Aug 2020San Diego, California, UsImagion Biosystems has developed a novel imaging technology that can detect, locate and characterize solid tumors at a much greater level of sensitivity that other diagnostic methods. I joined Imagion in 2016 when it was a subsidiary of Manhattan Scientifics Inc. (MSI) and in need of funding to further develop the technology and prepare for human studies. In late 2016 the Company was spun out from MSI and we raised $4.6 million in two separate seed round. In June 2017, Imagion was listed on the Australia Stock Exchange and we raised AUD $12 million in a fully subscribed offering. -
Independent ConsultantIndependent Consultant 2016 - Dec 2018Helping early and growth-stage companies: - Raising capital - M&A execution and integration - Overseas operations - Business startups - Financial and operational management
-
Chief Financial OfficerDiscoverx Corporation Aug 2016 - Aug 2017Fremont, Ca, UsDiscoverX is a drug discovery services company that provides pharma with safety and efficacy information about their compound libraries without conducting expensive animal and human studies. DiscoverX services enable companies to focus their resources on drug candidates that have the highest probability of success.I joined DiscoverX in 2016 to prepare the company for sale and assist the CEO with the process. In July 2017, Eurofins Scientific announced the acquisition of DiscoverX. -
Chief Financial OfficerVerdezyne, Inc. 2011 - 2016Verdezyne is a privately-held industrial biotechnology company that uses engineered micro-organisms to produce industrial chemicals from agricultural by-products. When I joined as CFO, it was a small, underfunded, research-stage company with no functioning Finance, HR or Marketing capabilities. Since then I raised $160 million in equity, debt and grants, created a business development and administrative infrastructure positioning Verdezyne to begin construction of its first commercial plant in Malaysia in 2016.
-
PresidentCanyonside Advisors Llc Feb 2009 - Jul 2011Canyonside Advisors provides services to businesses looking to monetize intellectual property, raise capital and complete an M&A transaction.
-
Interim ProfessionalTatum Llc 2009 - 2010Atlanta, Ga, Us -
Chief Financial OfficerMicroislet, Inc. 2008 - 2009UsMicroIslet was a publicly held, early-stage life science company working on a novel therapy for type 1 diabetes. I joined as CFO when the Company had exhausted its existing funding sources and had been unsuccessful at attracting new investors. I structured a recapitalization to reduce its debt load, cut costs and began rigorous financial planning. Unfortunately, the convergence of the 2008 capital market collapse, along with MicroIslet’s situation made it impossible to continue operations. In 2009, the company converted its reorganization to Chapter 7 liquidation and we sold off the assets. -
Director Of FinanceMillipore Corporation Jul 2006 - Jan 2008Burlington, Ma, UsFollowing the acquisition by Millipore, I accepted a position with the company’s $650 million Bioscience Division. My responsibilities related primarily to integration activities, which included harmonization of reporting systems, transferring accounting functions to headquarters and overall financial management of the legacy businesses. During this time I also served as the financial due diligence lead on three acquisition projects. -
Vp FinanceSerologicals Corporation Mar 2003 - Jul 2006After acquiring Chemicon, Serologicals kept the original management team intact to run a newly created Research Division. Through a combination of 15% to 20% organic growth and acquisitions totaling approximately $300 million, the Division grew from $50 million in 2003 to $140 million in 2005. During this period, I led diligence on four completed acquisitions, served as a steering committee member and functional lead on an SAP implementation and participated in numerous business initiatives. As Serologicals was a public company, we implemented Sarbanes-Oxley controls with no deficiencies noted. In March 2006, I joined a small team of company executives to execute the sale of the Company. On July 14, Millipore Corporation acquired Serologicals for $1.4 billion.
-
Chief Financial OfficerChemicon International Oct 2000 - Mar 2003UsChemicon was a privately held biological research tools company with revenues of $27 million in 2000, which grew to over $40 million in 2002. As CFO, I was in charge of Finance and IT, including M&A due diligence, treasury as well as roles in operational aspects of the business. In June 2002, I assumed management of Marketing and Product Management. In late 2002, I organized a limited auction of the company and sold Chemicon to Serologicals Corporation for $98 million in April 2003. -
Vp FinanceVista Information Solutions, Inc. Aug 1995 - Oct 2000VISTA was a publicly held internet real estate information company, which grew from $7 million in 1995 to $85 million in 2000. Most of this growth occurred as a result of several strategic acquisitions. During this period the company achieved a significant turnaround in profitability.- Conducted diligence, valuation and integration of seven acquisitions in a two-year period.- Managed treasury functions and raised nearly $90 million in capital through private equity investors and commercial lending arrangements.- Led the development of several custom software applications including order entry, contract management and a Web-based sales information system. - Supervised and participated in the company’s legal affairs and communications with investors, investment analysts and business press. - Participated in a variety of strategic initiatives and ventures including restructurings, business startups, partnerships and technology projects.
Brian Conn Skills
Start Ups
Mergers And Acquisitions
Due Diligence
Finance
Mergers
Strategic Planning
Forecasting
Biotechnology
Management
Managerial Finance
Restructuring
Strategy
Private Equity
Valuation
Analysis
Life Sciences
Sarbanes Oxley Act
Pharmaceutical Industry
Cross Functional Team Leadership
Investments
Commercialization
Product Management
Lifesciences
Accounting
Investor Relations
Acquisition Integration
Financial Reporting
Venture Capital
Erp Implementations
Sec Filings
Corporate Governance
Medical Devices
Business Process
Banking
Business Planning
Integration
U.s. Sec Filings
Brian Conn Education Details
-
Arizona State UniversityFinance -
Columbia Basin CollegeBusiness
-
Kamiakin High School
Frequently Asked Questions about Brian Conn
What company does Brian Conn work for?
Brian Conn works for Abtherx
What is Brian Conn's role at the current company?
Brian Conn's current role is CFO for early stage biotech companies.
What is Brian Conn's email address?
Brian Conn's email address is bc****@****ore.com
What is Brian Conn's direct phone number?
Brian Conn's direct phone number is +185844*****
What schools did Brian Conn attend?
Brian Conn attended Arizona State University, Columbia Basin College, Kamiakin High School.
What skills is Brian Conn known for?
Brian Conn has skills like Start Ups, Mergers And Acquisitions, Due Diligence, Finance, Mergers, Strategic Planning, Forecasting, Biotechnology, Management, Managerial Finance, Restructuring, Strategy.
Free Chrome Extension
Find emails, phones & company data instantly
Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Aero Online
Your AI prospecting assistant
Select data to include:
Total price:
$0.00
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial